ArticleFrontiers in oncology2022

Personalized treatment of brain metastases: Evolving survival prediction models may benefit from evaluation of serum tumor markers (narrative review).

Carsten Nieder et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.